Abstract
The objective of this article is to evaluate the efficacy of Doxazosin Mesylate Controlled Release Tablets for preoperative treatment of patients with pheochromocytoma. Between 2003 and 2008, 67 patients with confirmed diagnoses of pheochromocytoma were enrolled in this study. According to the drug used in preoperative management, patients were divided into two groups: Doxazosin Mesylate pretreatment group (n = 36) and Phenoxybenzamine pretreatment group (n = 31). Surgery was performed only in patients who met the optimal preoperative condition. The hematocrit decreased significantly (P < 0.001) after antiadrenergic therapy in patients pretreated with phenoxybenzamine or doxazosin. There was no significant difference between the fluid intakes during operation in both groups. The systolic arterial pressures both before and after induction of anesthesia were all significantly higher in the doxazosin patients than in the phenoxybenzamine group (P < 0.05). After tumor removed, the lowest systolic arterial pressure was significantly higher in doxazosin group than in phenoxybenzamine group (P < 0.05). The fluctuation of systolic arterial pressure during operation was more stable in doxazosin group than in phenoxybenzamine group (P < 0.05). Doxazosin mesylate controlled release tablet was as effective as phenoxybenzamine in preoperative volume expansion. Although phenoxybenzamine provided better arterial pressure control, patients pretreated with DOX experienced more stable perioperative hemodynamic changes, shorter preoperative management periods and more simple medication.
Similar content being viewed by others
References
J.W. Lenders, G. Eisenhofer, M. Mannelli, K. Pacak, Pheochromocytoma. Lancet 366(9486), 665–675 (2005)
K. Pacak, G. Eisenhofer, H. Ahlman, S.R. Bornstein, A.P. Gimenez-Roqueplo, A.B. Grossman et al. Pheochromocytoma: recommendations for clinical practice from the First International Symposium. October 2005. Nat. Clin. Pract. Endocrinal. Metab. 3(2), 92–102 (2007)
M. Brown, Pheochromocytoma, in Oxford Textbook of Medicine, 3rd edn., ed. by D.J. Weatherall, J.G.G. Ledingham, D.A. Warrell (Oxford University Press, Oxford, 1996), pp. 2553–2557
D.L. Bogdonoff, Pheochromocytoma: specialist cases that all must be prepared to treat? Cardiothorac. Vasc. Anesth. 16(3), 267–269 (2002)
Y. Miura, Yoshinaga.K. Doxazosin, A newly developed, selective alpha 1-inhibitor in the management of patients with pheochromocytoma. Am. Heart J. 116(6pt2), 1785–1789 (1988)
C. Prys-Roberts, J.R. Farndon, Efficacy and safety of doxazosin for perioperative management of patients with pheochromocytoma. World J. Surg. 26(8), 1037–1042 (2002)
D.L. Pan, H.Z. Li, Z.P. Zeng, The discussion of standards for clinical functional gradation and preoperative preparation of pheochromocytoma. Chin. J. Surg. 42(18), 1089–1092 (2004)
Y. Zhu, W.Q. Wang, Y.X. Wu, C.Y. Zhang, W.B. Rui, W.L. Zhou et al., Application of doxazosin controlled-release tablets in the pre-operative management of patients with pheochromocytoma: a pilot study. J. Mod. Urol. 12, 83–84 (2007)
S.Z. Langer, Presynaptic regulation of the release of catecholamines. Pharmacol. Rev. 32(7), 337–362 (1981)
L.X. Cubeddu, N.A. Zarate, C.B. Rosales, D.W. Zschaeck, Prazosin and propranolol in preoperative management of pheochromocytoma. Clin. Pharmacol. Ther. 32(2), 156–160 (1982)
V.A. Alabaster, M.J. Davey, The alpha 1-adrenoceptor antagonist profile of doxazosin: preclinical pharmacology. Br. J. Clin. Pharmacol. 21(Suppl. 1), 9S–17S (1986)
H.L. Elliott, P.A. Meredith, J. Vincent, J.L. Reid, Clinical pharmacological studies with doxazosin. Br. J. Clin. Pharmacol. 21(Suppl. 1), 27S–31S (1986)
A.N. van der Horst-Schrivers, M.N. Kerstens, B.H. Wolffenbuttel, Preoperative pharmacological management of phaeochromcytoma. Neth. J. Med. 64(8), 290–295 (2006)
M. Brauckhoff, O. Gimm, H. Dralle, Preoperative and surgical therapy in sporadic and familial pheochromocytoma. Front Horm Res. 31, 121–144 (2004)
Acknowledgements
This work was supported by Shanghai Municipal Natural Science Foundation (No. 09ZR1418500), grant from the Science and Technology Commission of Shanghai Municipality.
Author information
Authors and Affiliations
Corresponding author
Additional information
Hong-chao He is listed as co-first author.
Rights and permissions
About this article
Cite this article
Zhu, Y., He, Hc., Su, Tw. et al. Selective α1-adrenoceptor antagonist (controlled release tablets) in preoperative management of pheochromocytoma. Endocr 38, 254–259 (2010). https://doi.org/10.1007/s12020-010-9381-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-010-9381-x